SH2 Domain Containing 4A (SH2D4A) (N-Term) Peptide
SH2D4A
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all SH2D4A products
- SH2D4A (SH2 Domain Containing 4A (SH2D4A))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- IWKKVAEKEE LEQGSRPAPT LEEEKIRSLS SSSRNIQQML ADSINRMKAY
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-SH2D4A Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
SH2 Domain Containing 4A (SH2D4A) peptide
SH2D4A Reactivity: Human, Dog Host: Synthetic BP, Imm
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SH2D4A (SH2 Domain Containing 4A (SH2D4A))
- Synonyms
- SH2D4A Peptide, sh2a Peptide, PPP1R38 Peptide, SH2A Peptide, 2210402M20Rik Peptide, SH2 domain containing 4A Peptide, SH2D4A Peptide, sh2d4a Peptide, Sh2d4a Peptide
- Background
-
SH2D4A inhibits estrogen-induced cell proliferation by competing with PLCG for binding to ESR1, blocking the effect of estrogen on PLCG and repressing estrogen-induced proliferation. SH2D4A may play a role in T-cell development and function.
Alias Symbols: FLJ20967, SH2A, PPP1R38
Protein Size: 454 - Molecular Weight
- 53 kDa
- Gene ID
- 63898
- NCBI Accession
- NM_022071, NP_071354
- UniProt
- Q9H788
-
You are here:
